Back to Authors

Schwarz, Niklas

0000-0002-4064-3073

Mayo Clinic

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen, 72076 Tuebingen, Germany.

Citations 2

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy

Science Translational Medicine | September 2, 2021 | Volume: 13 | Issue: 609 | Pages: No page available

10.1126/scitranslmed.aaz4957 | PMID 34516822

4-Aminopyridine is a potential therapeutic option for a subgroup of patients with KCNA2 -encephalopathy and gain-of-function variants.
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

Brain | February 23, 2017 | Volume: 140 | Issue: 5 | Pages: 1316-1336

10.1093/brain/awx054 | PMID 28379373